In vitro activation of mouse macrophages by rat lymphocyte mediators
- PMID: 950467
In vitro activation of mouse macrophages by rat lymphocyte mediators
Abstract
Macrophage-activating factors (MAF)3 were released by presensitized rat lymphocytes stimulated in vitro with the appropriate antigens. Different supernatants of presensitized rat lymphocytes specifically stimulated in vitro with several different mouse, dog, and rat tumor or normal cells were capable of rendering normal rat and mouse macrophages nonspecifically cytotoxic in vitro to their respective syngeneic tumor cells. The release of active mediators by rat lymphocytes sensitized in vivo was dependent upon immunologically specific recognition of an antigen in vitro. When rat lymphocytes were incubated in vitro with antigens unrelated to the in vivo sensitizing antigens, no release of MAF occurred. Once rat MAF was released, it activated both syngeneic (rat) and xenogeneic (mouse) macrophages to kill tumor cells in vitro. These activated marcophages destroyed all syngeneic tumor targets. Such cytotoxicity was obtained even when the cells used to elicit release of MAF were totally unrelated to the target tumor cells. The data thus demonstrated that MAF can cross strain and even species specificities and can activate macrophages to kill tumors in a nonspecific manner. The cytotoxicity mediated by in vitro activated mouse macrophages decreased with time once the macrophages were removed from MAF; and by 7 days postactivation, the macrophages were not cytotoxic. However, when incubated again with MAF, significant reactivation was observed. This suggested that activation of macrophages in vivo may be a continuous process of lymphocyte-macrophage interaction.
Similar articles
-
Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A.Cancer Res. 1976 Oct;36(10):3608-15. Cancer Res. 1976. PMID: 953987
-
Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.J Immunol. 1985 Sep;135(3):2199-205. J Immunol. 1985. PMID: 3894520
-
Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.Cancer Res. 1979 Mar;39(3):881-92. Cancer Res. 1979. PMID: 427777
-
Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.Behring Inst Mitt. 1984 May;(74):157-73. Behring Inst Mitt. 1984. PMID: 6383322 Review.
-
Macrophage-lymphocyte interaction and antigen recognition.Fed Proc. 1975 Jul;34(8):1743-8. Fed Proc. 1975. PMID: 1093892 Review.
Cited by
-
Breakdown of articular cartilage proteoglycans by lymphokine-activated macrophages.Inflammation. 1978 Jun;3(2):195-201. doi: 10.1007/BF00910739. Inflammation. 1978. PMID: 216634
-
Immune surveillance and natural resistance: an evaluation.Cancer Immunol Immunother. 1986;21(2):85-92. doi: 10.1007/BF00199854. Cancer Immunol Immunother. 1986. PMID: 2936448 Free PMC article. Review.
-
Kinetics and ultrastructural studies of the induction of rat alveolar macrophage fusion by mediators released from mitogen-stimulated lymphocytes.Am J Pathol. 1981 May;103(2):234-46. Am J Pathol. 1981. PMID: 7234965 Free PMC article.
-
Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor.Proc Natl Acad Sci U S A. 1985 Jun;82(11):3688-92. doi: 10.1073/pnas.82.11.3688. Proc Natl Acad Sci U S A. 1985. PMID: 3159018 Free PMC article.
-
Alteration of physiological activity of activated macrophages through L-arginine metabolism.Jpn J Cancer Res. 1991 May;82(5):539-46. doi: 10.1111/j.1349-7006.1991.tb01884.x. Jpn J Cancer Res. 1991. PMID: 1905700 Free PMC article.